EcoR1 Capital LLC 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:33 pm Sale |
2024-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
EcoR1 Capital LLC | 10,630,736 9.900% |
-2,700,000 (-20.25%) |
Filing |
| 2023-10-16 3:33 pm Purchase |
2023-10-13 | 13G | Tango Therapeutics, Inc. TNGX |
EcoR1 Capital LLC | 13,330,736 13.100% |
5,503,100 (+70.30%) |
Filing |
| 2023-09-21 5:16 pm Purchase |
2023-09-11 | 13G | Tango Therapeutics, Inc. TNGX |
EcoR1 Capital LLC | 7,827,636 7.700% |
7,827,636 (New Position) |
Filing |